ICU Medical (ICUI)
(Delayed Data from NSDQ)
$117.98 USD
+0.45 (0.38%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $117.92 -0.06 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
ICUI 117.98 +0.45(0.38%)
Will ICUI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ICUI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ICUI
Implied Volatility Surging for ICU Medical (ICUI) Stock Options
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
ICUI: What are Zacks experts saying now?
Zacks Private Portfolio Services
BellRing Brands (BRBR) Q2 Earnings and Revenues Top Estimates
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
Align Technology (ALGN) Q1 Earnings Top, 2024 Sales View Up
Other News for ICUI
ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Staar Surgical Co's Meteoric Rise: Unpacking the 21% Surge in Just 3 Months
Needham starts ICU Medical at hold, cites limited revenue growth
ICU Medical initiated with neutral view at Needham, here's why
ICU Medical: Hold Rating Affirmed Amid Balanced Growth Prospects and Valuation